Pande Atul: insider trades.
Pande Atul reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($125K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Pande Atul
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Immunovant, Inc. (IMVT) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-28 | Immunovant, Inc. | S | 1,500 | $43.27 | 116,731 | Form 4 |
| 2026-08-28 | Immunovant, Inc. | M | 1,500 | $8.43 | 118,231 | Form 4 |
| 2026-07-24 | Immunovant, Inc. | M | 1,500 | $8.43 | 118,231 | Form 4 |
| 2026-07-24 | Immunovant, Inc. | S | 1,500 | $39.8 | 116,731 | Form 4 |
Questions
What stock did Pande Atul buy or sell?
Pande Atul reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($125K), across 1 company.
Is Pande Atul the same person as other filers with this name?
This page covers SEC CIK 1643071 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/pande-atul-1643071.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.